Canlyniadau Chwilio - Elton Chan

  • Dangos 1 - 5 canlyniadau o 5
Mireinio'r Canlyniadau
  1. 1
    Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase <i>BRAF</i> -mutant lung cancer

    Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase <i>BRAF</i> -mutant lung cancer gan Ross A. Okimoto, Luping Lin, Victor Olivas, Elton Chan, Evan Markegard, Andrey Rymar, Dana S. Neel, Xiaohong Chen, Golzar Hemmati, Gideon Bollag, Trever G. Bivona

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer

    Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer gan Luping Lin, Saurabh Asthana, Elton Chan, Sourav Bandyopadhyay, Maria M. Martins, Victor Olivas, Jenny Yan, Luu Pham, Mingxue Michelle Wang, Gideon Bollag, David B. Solit, Eric A. Collisson, Charles M. Rudin, Barry S. Taylor, Trever G. Bivona

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

    NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer gan Collin M. Blakely, Evangelos Pazarentzos, Victor Olivas, Saurabh Asthana, Jenny Yan, Irena Tan, Gorjan Hrustanovic, Elton Chan, Luping Lin, Dana S. Neel, W. H. Newton, Kathryn Bobb, Timothy Fouts, Jeffrey Meshulam, Matthew A. Gubens, David M. Jablons, Jeffrey R. Johnson, Sourav Bandyopadhyay, Nevan J. Krogan, Trever G. Bivona

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

    RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer gan Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos, Asmin Tulpule, Saurabh Asthana, Collin M. Blakely, Ross A. Okimoto, Luping Lin, Dana S. Neel, Amit J. Sabnis, Jennifer C. Flanagan, Elton Chan, Marileila Varella‐Garcia, Dara L. Aisner, Aria Vaishnavi, Sai‐Hong Ignatius Ou, Eric A. Collisson, Eiki Ichihara, Philip C. Mack, Christine M. Lovly, Niki Karachaliou, Rafael Rosell, Jonathan W. Riess, Robert C. Doebele, Trever G. Bivona

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

    The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies gan Luping Lin, Amit J. Sabnis, Elton Chan, Victor Olivas, Lindsay Cade, Evangelos Pazarentzos, Saurabh Asthana, Dana S. Neel, Jenny Yan, Xinyuan Lu, Luu Pham, Mingxue M Wang, Niki Karachaliou, María González Cao, José Luís Manzano, José Luis Ramírez, J.M. Sanchez Torres, Fiamma Buttitta, Charles M. Rudin, Eric A. Collisson, Alain P. Algazi, Eric M. Robinson, Iman Osman, Eva Muñoz‐Couselo, Javier Cortés, Dennie T. Frederick, Zachary A. Cooper, Martin McMahon, Antonio Marchetti, Rafael Rosell, Keith T. Flaherty, Jennifer A. Wargo, Trever G. Bivona

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: